About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker SGMOQ

Latest patent grants
GrantedPatentOwnerTypeSource
Oct 27, 202612774475
Compositions and methods for producing recombinant AAV
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
Oct 13, 202612758654
Methods and compositions for the treatment of fabry disease
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
Sep 29, 202612747273
HTT repressors comprising a zinc-finger protein transcription factor
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
Jun 16, 202612653861
Methods and compositions for treating Huntington's Disease
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
May 19, 202612630839
Compositions for the treatment of Fabry disease
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
Mar 3, 202612565685
Engineering AAV
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
Feb 17, 202612551575
Htt repressors and uses thereof
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
Jan 6, 202612516098
Chimeric antigen receptor mediated cell targeting
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
Dec 30, 202512509703
Controlled transgene expression in regulatory t cells
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
Dec 16, 202512497632
Clinical parameters by expression of factor VIII
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
Jun 3, 202512318427
Methods and compositions for modulation of tau proteins
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗
Nov 12, 202412139517
Modulators of chromosome 9 open reading frame 72 gene expression and…
SGMOQ
Sangamo Therapeutics, Inc.
utilityGoogle Patents ↗

12 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 7:48 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances